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MaOBJECTIVES The aim of this study was to determine the prevalence of right intraventricular dyssynchrony, its
determinants and prognostic impact in idiopathic, heritable, and anorexigen-induced pulmonary arterial hypertension.
BACKGROUND Right ventricular dyssynchrony has been described in pulmonary arterial hypertension, but no evidence
is available on its prognostic impact and evolution after therapy.
METHODS In 83 consecutive therapy-naïve patients, right ventricular dyssynchrony was evaluated by 2-dimensional
speckle-tracking echocardiography calculating the standard deviation of the times to peak-systolic strain for the 4
mid-basal right ventricular segments (RV-SD4). After baseline (World Health Organization [WHO] class, pulmonary
hemodynamics, 6-min walk test [6MWT]), a second assessment was performed after 12 months or when clinical
worsening occurred.
RESULTS Patients with right ventricular dyssynchrony (RV-SD4 >18 ms) had advanced WHO class, worse 6MWT,
right ventricular remodeling, and hemodynamic proﬁle compared with patients #18 ms. Determinants of dyssynchrony
included pulmonary vascular resistance, QRS duration, and right ventricular end-diastolic area (r2 ¼ 0.38;
p < 0.000001). At 12 months, 32.5% of patients presented clinical worsening (actuarial rates: 19% at 6 months, 31% at
1 year). Multivariable models for clinical worsening prediction showed that the addition of RV-SD4 to clinical and
hemodynamic variables (WHO IV, 6MWT, and cardiac index) signiﬁcantly increased the prognostic power of the model
(0.74 vs. 0.81; p ¼ 0.005, 95% conﬁdence interval [CI]: 0.02 to 0.11). Receiver operating characteristic analysis iden-
tiﬁed RV-SD4 $ 23 ms as the best cutoff value for clinical worsening prediction (95% negative predictive value).
At 12 months, normalization of dyssynchrony was achieved in patients with a large reduction of pulmonary vascular
resistance (–42  4%).
CONCLUSIONS Right ventricular dyssynchrony is frequent in pulmonary arterial hypertension, is an independent
predictor of clinical worsening, and might regress during effective treatments. (J Am Coll Cardiol Img 2015;8:642–52)
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AB BR E V I A T I O N S
AND ACRONYM S
IVA = isovolumic acceleration
IVS = interventricular septum
LVEId = left ventricular
diastolic eccentricity index
LVEIs = left ventricular
systolic eccentricity index
PW-TDI = pulsed waved tissue
Doppler imaging
RV = right ventricular
RVEDA = right ventricular
end-diastolic area
RVESA = right ventricular
end-systolic area
RVFAC = right ventricular
fractional area change
RVFW = right ventricular
free wall
RV-SD4 = standard deviation
of the times to peak-systolic
strain for the 4 mid-basal right
ventricular segments
S1 = isovolumic contraction
velocity
S2 = peak systolic velocity
STE = speckle-tracking
echocardiography
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643patient functional capacity and survival (3). Although
RV mechanical dyssynchrony (RVD) has recently been
described in pulmonary hypertension (4–6), currently
we do not have evidence on its prognostic relevance.
To address this issue, RV mechanics should be evalu-
ated taking into account several methodological con-
siderations such as a larger and more homogeneous
PAH population than previous studies, absence of
confounding factors, adequate management and
follow-up of patients, and application of new echo-
cardiographic techniques for mechanical delay
evaluation.
Accordingly, the aims of this study were
to determine the prevalence of RVD in a large cohort of
idiopathic, heritable, and anorexigen-induced pul-
monary arterial hypertension (IPAH, HPAH, APAH),
therapy-naïve patients, to better elucidate the factors
inﬂuencing RVD, to evaluate the prognostic impact of
RVD and its evolution on long-term follow-up.
METHODS
POPULATION AND STUDY PROTOCOL. The study
population included 83 consecutive therapy-naïve
patients with IPAH, HPAH, and APAH, without severe
tricuspid regurgitation or electrocardiographic signs
of intraventricular conduction delay to avoid other
confounding factors for RVD evaluation. Patients
were referred to our center from January 1, 2010 to
December 31, 2011, and diagnosis of PAH had
been made according to European guidelines (7).
Three patients with suboptimal echocardiographic
images were excluded from all subsequent analyses.
Thus, the patient study group consisted of 80
patients.SEE PAGE 653Patients with IPAH, HPAH, and APAH should
be considered a homogeneous population with com-
mon pathophysiological pathways and histologic
ﬁndings (8).
Baseline evaluation included medical history,
physical examination, a nonencouraged 6-min walk
test (6MWT), right heart catheterization (RHC), and
echocardiographic assessment. Thereafter, patients
started a speciﬁc PAH treatment, according to Euro-
pean guidelines (7).
All patients were prospectively followed-up for 12
months with phone calls (every month) and clinical
examinations (every 1 to 3 months) for the presence
of clinical worsening (CW), deﬁned as a reduction in
exercise capacity (–15% compared with baseline
6MWT), worsening in World Health Organization
(WHO) functional class, or clinical deteriorationrequiring hospital admission (need for intra-
venous diuretic or inotropic drugs, need for
new PAH therapies, lung transplantation, or
death) (9). The CW was evaluated by 2 phy-
sicians (V.C.D., P.R.) blinded on the echocar-
diographic results.
A second assessment (WHO class, 6MWT,
RHC, echocardiography) was performed after
12 months or when CW occurred. All patients
were included in the study protocol after
informed consent. The protocol was
approved by the Institutional Review Board
for human studies of the Policlinico Umberto
I-Sapienza University of Rome (Protocol n.
42412).
RIGHTHEARTCATHETERIZATION. Hemodynamic
evaluation was made with standard tech-
nique, as previously described (10).
STANDARD ECHOCARDIOGRAPHY. Echocar-
diographic studies were performed using
commercially available equipment (Vivid S6,
GE Medical Systems, Milan, Italy) and ac-
quired within 24 hours from RHC. Standard
M-mode, 2-dimensional (2D) and Doppler
images were obtained during breath hold and
stored in cine-loop format from 3 consecutive
beats. Measurements were performed in
accordance with the American Society of Echocardi-
ography Guidelines (11).
The following parameters and derived measures
were considered in the analysis: right atrial area (RA
area), right ventricular end-diastolic area (RVEDA),
right ventricular end-systolic area (RVESA), right
ventricular fractional area change (RVFAC) %
(RVFAC ¼ [RVEDA – RVESA]/RVEDA  100), tricuspid
annular plane systolic excursion (TAPSE), left ven-
tricular systolic eccentricity index (LVEIs) and left
ventricular diastolic eccentricity index (LVEId), and
presence of pericardial effusion.
Pulsed-wave tissue Doppler imaging (PW-TDI) was
used for the following measures: isovolumic con-
traction velocity (S1), isovolumic acceleration (IVA),
and peak systolic velocity (S2). All reported mea-
surements are the averages derived from 3 consecu-
tive cardiac cycles.
2D SPECKLE-TRACKING ECHOCARDIOGRAPHY. Acquisition.
For speckle tracking analysis (EchoPAC workstation
7.0.1, GE Medical Systems), standard grayscale 2D
images in the 4-chamber apical view were acquired
and digitally stored in 3 beats cine-loop format.
Analysis. To assess the segmental characteristics of
the RV, we adopted the 6-segment model, excluding
the apical segments for the analysis because of the
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644high variability of that segments observed even in
normal subjects. This decision is supported by
software-related technical issues (12).
To quantify right intraventricular dyssynchrony,
we considered longitudinal strain and calculated the
standard deviation of the times to peak-systolic strain
for the 4 mid-basal RV segments corrected to the
R-R interval between 2 QRS complexes, according to
the Bazett’s formula (13), and called RV-SD4. Forty
healthy controls, matched for age, sex, and body mass
index (BMI), were included to deﬁne the normal
range of RV-SD4.
To deﬁne intraobserver and interobserver vari-
ability, 2D speckle tracking echocardiography (STE)
measurements were repeated for all patients by the
same observer (B.R.) and by a second independent
observer (R.M.).
STATISTICAL ANALYSIS. Continuous data are
expressed as mean  SD, and categorical data are
expressed as counts and proportions. Two-group
comparisons were performed with unpaired or
paired 2-tailed Student t tests for means if the
data were normally distributed or with Wilcoxon
rank-sum tests if the data were not normally distrib-
uted. Chi-square or Fisher exact tests were used to
analyze the categorical data.
Actuarial freedom from episodes of CW was
determined by the Life Table method. Kaplan-Meier
(product-limit) graphs were used to show CW over
time. Patients who were without CW were censored
on the date of the conclusion of the study.FIGURE 1 Intraobserver and Interobserver Variability Assessed by t
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For RV-SD4 measurement, the difference in each pair of measurements w
1.76 (95% CI: –3.37 to þ3.57) (average percentage variability 6.2%). (B) I
percentage variability 7.2%). CI ¼ conﬁdence interval; RV ¼ right ventricl
the 4 mid-basal right ventricular segments.Multivariate Cox regression models were con-
structed to identify risk factors for CW. First, a base
model was generated that included variables signiﬁ-
cantly (p < 0.05) associated with CW on univariate
analysis (age, sex, WHO class, 6MWT, and hemody-
namic and echocardiographic parameters). A p value
of 0.10 was the criterion to remove covariates from
the model until the most parsimonious model was
sought. A second comparative Cox model was used to
assess the relative prognostic power of RV-SD4. The
proportional-hazards assumptions were assessed
with Durbin-Watson test.
The c-statistic was calculated for each model and
compared by the method of DeLong et al. (14) to
determine the incremental prognostic information of
model-2.
A receiver operating characteristic (ROC) curve was
used to test the ability of RV-SD4 to detect CW
(optimal cutoff point highest and to the left on the
ROC curve).
Regression analysis was performed to assess the
relations between RV-SD4 and PVR changes during
follow-up, identifying a quadratic model as the most
accurate yet parsimonious.
For RV-SD4 measurement, intraobserver and
interobserver variability was assessed by the Bland-
Altman method: 0.10  1.76 (95% conﬁdence
interval [CI]: –3.37 to þ3.57) (average percentage
variability 6.2%) and 0.14  2.03 (95% CI: –3.85
to þ4.13) (average percentage variability 7.2%),
respectively, which can be considered acceptable for
our clinical purpose (Figure 1).he Bland-Altman Method
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as plotted against the pair’s mean. (A) Intraobserver variability 0.10 
nterobserver variability 0.14  2.03 (95% CI: –3.85 to þ4.13) (average
e; RV-SD4 ¼ standard deviation of the times to peak-systolic strain for
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645All statistical analyses were performed using
SPSS software (version 20.0, IBM Corp. 2011, Milan,
Italy) and MedCalc (version 13.3, 2013, Mariakerke,
Belgium).
RESULTS
Baseline characteristics of the 80 PAH patients are
summarized in Table 1. The majority of patients was
female, WHO class III, with severe PAH and impaired
effort capacity.
As expected, PAH patients presented impaired
morphologic and systolic function echocardiographic
parameters compared with control subjects (Table 2).
VARIABILITY OF RV DYSSYNCHRONY MODELS IN
NORMAL SUBJECTS BY STE ANALYSIS. Analyzing
the time to peak strain of the 6 RV segments among
normal subjects, we observed a high variability of the
apical segments of both the right ventricular free wall
(RVFW) and the interventricular septum (IVS)TABLE 1 Demographic, Clinical, and Hemodynamic
Characteristics of the Study Population
Diagnosis
Idiopathic PAH 71 (89)
Heritable PAH 5 (6)
Anorexigen-induced PAH 4 (5)
Sex, M/F 28/52
Age, yrs 57  14
Weight, kg 68  16
Height, cm 163  9
Follow-up, days 416  210
Functional class
WHO II 28 (35)
WHO III 47 (59)
WHO IV 5 (6)
6MWT, m 429  119
Hemodynamics
RAP, mm Hg 7.8  4.7
PAP, mm Hg 49  15
Cardiac index, l/min/m2 2.7  0.7
PWP, mm Hg 9  3
PVR, WU 10.1  4.8
Compliance, ml/mm Hg 1.5  1.1
QRS, ms 85  14
First-line therapy
Calcium-channel blockers 5 (6)
ERA 33 (41)
PDE5i 28 (35)
Epoprostenol 4 (5)
Treprostinil 10 (13)
Values are n (%), n, or mean  SD.
6MWT ¼ nonencouraged 6-min walk test; ERA ¼ endothelin receptor antago-
nist; PAH ¼ pulmonary arterial hypertension; PAP ¼ mean pulmonary arterial
pressure; PDE5i ¼ phosphodiesterase 5 inhibitor; PVR ¼ pulmonary vascular
resistance; PWP ¼ mean pulmonary wedge pressure; RAP ¼ mean right atrial
pressure; WHO ¼ World Health Organization; WU ¼ Wood Unit.compared with the mid and basal segments (395  49
ms vs. 386  33 ms and 384  34 ms, respectively).
Consequently, we found a higher standard deviation
when RVD was quantiﬁed by the 6-segment model
in respect to the 4-segment model (16  10 ms vs.
9  5 ms, respectively; p ¼ 0.03), even if corrected to
the R-R intervals (15  9 ms vs. 8  5 ms, respectively;
p ¼ 0.03).
RV DYSSYNCHRONY. The mean 2D strain value of the
basal and medium segments of both the RVFW and
the IVS were 21.2  6.7%, 19.4  7.0%, 18.4  10.1%,
and 16.9  10.6%, respectively, with a delayed time to
maximal deformation of the RVFW compared with
the IVS (408  61 ms vs. 376  50 ms, respectively).
RVD determined by RV-SD4 was 27  23 ms in the
patients group and 8  5 ms in the control group.
Using the upper 95% limit of normal (mean þ 2SD) of
the control group, we deﬁned a cutoff value of 18 ms
as criterion for RVD. According to this criterion, RVD
was present in 48 patients (60%). An example of a
normal subject (A) compared with a patient with
signiﬁcant RVD (B) is shown in Figure 2. As shown inTABLE 2 Comparison of Echocardiographic Features Between PAH Patients
and Normal Subjects
Normal Subjects
(N ¼ 40)
PAH
(N ¼ 80) p Value
Heart rate, beats/min 69  12 76  12 0.03
PVC, ms 399  29 389  37 ns
Morphological features
RA area, cm2 14  2 30  10 <0.00001
RVEDA, cm2 14  2 25  7 <0.00001
RVESA, cm2 7  1 16  7 <0.00001
LVEId 0.99 (0.99–1.01) 1.27 (1.16–1.50) <0.0001
LVEIs 1.01 (0.99–1.05) 1.44 (1.20–1.73) <0.0001
Pericardial effusion 0 25 <0.0001
RV systolic function
RVFAC, % 53  3 37  11 <0.00001
TAPSE, mm 27  2 20  4 <0.00001
pTDI S1, cm/s 11.5  2.4 8.4  2.8 <0.0001
pTDI S2, cm/s 14.3  2.2 11.0  2.9 <0.0001
pTDI RV IVA, m/s2 4.0  0.6 2.7  0.8 <0.00001
Peak 2DS mid RVFW, % 32.0  4.8 19.4  7.0 <0.00001
Peak 2DS basal RVFW, % 31.7  6.8 21.2  6.7 <0.00001
Intraventricular dyssynchrony
RV-SD4, ms 8  5 27  23 <0.00001
Values are mean  SD, median (interquartile range), or n.
2DS basal RVFW ¼ 2-dimensional strain of the basal segment of the RVFW by Speckle-Tracking Echocardi-
ography; 2DS mid RVFW ¼ 2-dimensional strain of the mid segment of the RVFW by Speckle-Tracking Echo-
cardiography; IVA ¼ isovolumic acceleration; LVEId ¼ left ventricular end-diastolic eccentricity index; LVEIs ¼
left ventricular end-systolic eccentricity index; PAH ¼ pulmonary arterial hypertension; pTDI RV IVA ¼ right
ventricular isovolumic acceleration; pTDI S1 ¼ pulsed tissue Doppler peak isovolumic velocity at the basal RVFW
segment; pTDI S2 ¼ pulsed tissue Doppler peak systolic velocity at the basal RVFW segment; PVC ¼ pulmonary
valve closure; RA ¼ right atrium area; RV ¼ right ventricular; RVEDA ¼ right ventricular end-diastolic area;
RVESA ¼ right ventricular end-systolic area; RVFAC ¼ right ventricular fractional area change; RVFW ¼ right
ventricular free wall; RV-SD4 ¼ standard deviation of the times to peak-systolic strain for the 4 mid-basal RV
segments; TAPSE ¼ tricuspid annular plane systolic excursion.
FIGURE 2 Example of RVD Evaluation by STE in a Normal Subject and in a Patient With
Signiﬁcant RVD
(A) Normal subject. (B) Patient with signiﬁcant RVD by STE. The colored lines represent
the time-interval between QRS onset and peak systolic strain for each RV segment for RV-
SD4 measurement (red line: basal RVFW; blue line: mid RVFW; yellow line: basal IVS;
light-blue line: mid IVS). AVC ¼ aortic valve closure; IVS ¼ interventricular septum; RV ¼
right ventricle; RVD ¼ right ventricular dyssynchrony; RVFW ¼ right ventricular free wall;
STE ¼ speckle tracking echocardiography; other abbreviation as in Figure 1.
TABLE 3 Comparison of Clinical, Echocardiographic, and
Hemodynamic Characteristics of PAH Patients Based on
RV-SD4 >2 SD UNL
RV-SD4 #18
(n ¼ 32)
RV-SD4 >18
(n ¼ 48) p Value
Age, yrs 56  15 57  15 NS
Weight, kg 65  16 70  15 NS
Height, cm 163  10 163  9 NS
Sex, M/F 8/24 16/32 NS
QRS, ms 81  14 83  15 NS
WHO 2.4 2.9 <0.0001
6MWT, m 472  104 401  120 <0.007
Hemodynamics
RAP, mm Hg 6.6  3.9 8.6  5.0 0.06
PAP, mm Hg 45  13 50  15 NS
PWP, mm Hg 10.0 9.6 NS
Cardiac index,
l/min/m2
3.0  0.7 2.5  0.8 0.007
PVR, WU 7  3 10  5 0.006
Echocardiography
Heart rate, beats/min 76  10 75  13 NS
PVC, ms 391  31 388  41 NS
RA area, cm2 25  7 33  11 0.0007
RVEDA, cm2 21  7 28  7 0.0001
RVESA, cm2 13  6 18  6 0.0004
RVFAC, % 40  11 36  11 0.06
TAPSE, mm 21  3 19  4 NS
LVEId 1.22 (1.08–1.39) 1.29 (1.19–1.60) 0.01
LVEIs 1.24 (1.15–1.56) 1.55 (1.26–1.90) 0.003
Pericardial effusion 3 (9) 21 (43) <0.0001
pTDI S1, cm/s 9.2  3.1 7.9  2.5 0.06
pTDI S2, cm/s 11.1  2.3 11.1  3.3 NS
pTDI RV IVA, m/s2 3.1  0.7 2.5  0.7 0.001
Peak 2DS mid
RVFW, %
22  6 18  7 0.002
Peak 2DS basal
RVFW, %
22  7 20  6 NS
Systolic shortening
time, ms
311  48 340  45 0.04
Post-systolic
shortening, ms
–5  38 38  49 0.001
Values are mean  SD, n, median (interquartile range), or n (%).
UNL ¼ upper normal limit; other abbreviations as in Tables 1 and 2.
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646Table 3, analyzing the clinical, hemodynamic, and
echocardiographic proﬁles of the 2 groups of patients
divided by the 95% upper limit value of the normal
population of RV-SD4 (18 ms), the 2 groups were
comparable for demographic characteristics. Patients
with RVD had a more advanced WHO functional
class, worse exercise tolerance, and more impaired
hemodynamic condition compared to patients#18ms.
Those patients also had worse RV morphologicalremodeling and more frequently pericardial effusion
compared to the other patients, but similar RV sys-
tolic function. Notably, in patients with RV-SD4
>18 ms, RV mid- and basal-segment shortening time
occurred 38  49 ms after pulmonary valve closure,
representing 10  13% of the entire shortening time
(340  45 ms).
FACTORS INFLUENCING RV DYSSYNCHRONY. We
performed a stepwise backward multivariate regres-
sion analysis to determine the most important RV
morphologic, electrical, and hemodynamic parame-
ters inﬂuencing right intraventricular mechanical
TABLE 4 Comparison of Clinical, Echocardiographic, and Hemodynamic
Characteristics of the Overall Cohort Based on Clinical Worsening
No CW
(n ¼ 54)
CW
(n ¼ 26) p Value
Age, yrs 56  16 59  14 NS
Weight, kg 67  15 72  18 NS
Height, cm 164  10 161  7 NS
Sex, M/F 18/36 6/20 NS
QRS, ms 81  14 85  16 NS
WHO 2.5  0.5 3.2  0.4 <0.0001
6MWT, m 475  102 334  94 <0.0001
Hemodynamics
RAP, mm Hg 6.5  3.3 11.2  5.3 <0.0001
PAP, mm Hg 44  13 55  13 <0.001
Cardiac index, l/min/m2 3.0  0.7 2.0  0.5 <0.0001
PVR, WU 7  3 13  5 <0.0001
Echocardiography
Heart rate, beats/min 74  11 80  13 0.04
PVC, ms 398  29 372  46 0.003
RA area, cm2 26  7 39  11 <0.0001
RVEDA, cm2 23  7 30  7 0.0001
RVESA, cm2 14  6 21  7 <0.0001
RVFAC, % 41  10 31  10 <0.0001
TAPSE, mm 21  3 18  4 <0.001
LVEId 1.21 (1.08–1.32) 1.56 (1.27–2.07) 0.0001
LVEIs 1.25 (1.15–1.57) 1.81 (1.50–2.19) 0.0001
Pericardial effusion 12 (22) 13 (50) 0.001
pTDI S1, cm/s 9.2  2.7 6.9  2.6 <0.001
pTDI S2, cm/s 11.6  2.4 10.0  3.6 0.02
pTDI RV IVA, m/s2 3.0  0.7 2.2  0.6 <0.0001
Peak 2DS mid RVFW, % 22  6 15  5 <0.0001
Peak 2DS basal RVFW, % 23  6 17  6 <0.0001
Systolic shortening time, ms 324  49 339  65 NS
Post-systolic shortening, ms 3  41 48  52 0.0001
RV-SD4, ms 19  13 45  27 <0.0001
Values are mean  SD, n, median (interquartile range), or n (%).
CW ¼ clinical worsening; other abbreviations as in Tables 1 and 2.
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647delay. PVR (unstandardized coefﬁcient B 1.76, odds
ratio [OR]: 5.9; p ¼ 0.006), RVEDA (unstandardized
coefﬁcient B 0.96, OR: 2.6; p ¼ 0.002), and QRS
duration (unstandardized coefﬁcient B 0.36, OR: 1.4;
p ¼ 0.02) were found to be independent predictors of
intraventricular delay (r ¼ 0.62; r2 ¼ 0.38; p <
0.000001).
RV DYSSYNCHRONY AND CLINICAL WORSENING. In
the overall cohort, after a median follow-up of 297 
102 days, 26 of 80 patients presented with CW
(32.5%). Actuarial rates of CW were 19% at 6 months
and 31% at 1 year. Mean time to CW was 170  83 days.
No signiﬁcant differences were observed between
patients with and without CW regarding demographic
proﬁle (Table 4). As expected, the former group had
worse WHO functional class, 6MWT, hemodynamic
impairment, RV remodeling, and dysfunction
compared with patients without CW. Notably, the
average RV-SD4 among event-free survivors was
19  13 ms versus 45  27 ms among patients who
presented CW (p < 0.0001). Twenty-four of 26 events
(92.3%) occurred in patients with an RV-SD4 greater
than 18 ms.
Cox regression model 1 for CW prediction was
constructed with those variables signiﬁcantly result-
ing from univariate analysis excluding RV-SD4
(Table 5). Among demographic, clinical, hemody-
namic, and echocardiographic parameters, WHO
functional class IV, 6MWT, and cardiac index
remained independent predictors of CW (model 1:
0.74, 95% CI: 0.62 to 0.85; p ¼ 0.001) (Table 6). Add-
ing the RV-SD4 to model 1, we observed a signiﬁcant
improvement in c-statistics (model 2: 0.81, 95% CI:
0.70-0.91; p ¼ 0.0001) showing an improvement in
the prognostic power (0.81 vs. 0.74; 95% CI: 0.02 to
0.11; p ¼ 0.005) (Figure 3).
The ROC analysis identiﬁed a baseline RV-SD4 of 23
ms as the best cutoff value for CW prediction (area
under the curve 0.85, 95% CI: 0.75 to 0.93; SE 0.045).
An RV-SD4 of 23 ms showed 92% sensitivity, 63%
speciﬁcity, and a high negative predictive value of 95%
(positive predictive value 57%) for adverse outcomes.
The 6-month and 1-year event-free survival esti-
mates were 88% and 85%, respectively, for patients
with an RV-SD4 <23 ms compared with 62% and 45%,
respectively, for patients with a RV-SD4 $23 ms
(Figure 4).
RV DYSSYNCHRONY EVOLUTION. At 12 months,
patients without CW experienced a signiﬁcant
improvement in WHO functional class, exercise toler-
ance, all hemodynamic parameters, and RV chamber
morphological parameters (Table 7). In these patients,
RVD signiﬁcantly decreased at second evaluationcompared to baseline (19.57  14.0 ms vs. 14.96 
10.0 ms, respectively; p ¼ 0.001). Interestingly, a sig-
niﬁcant relationship was found between RV-SD4
improvement and RVEDA reduction (r2 ¼ 0.52;
p ¼ 0.001; y ¼ –2.8 þ 2.0x) and PVR decrease, with
those patients with the greatest reduction of PVR
showing a complete normalization of RV-SD4 (r2 ¼
0.59; p ¼ 0.0001; y ¼ 4.1 þ 0.2x – 0.007x2) (Figure 5).
Indeed, 10 patients showed complete regression of
RVD associated with a 42  4% reduction of PVR. On
the contrary, at the time of CW, patients presented a
signiﬁcant increase of RV-SD4 compared to baseline
(49.75  26.00 ms vs. 45.40  28.00 ms, respectively;
p ¼ 0.01) and to those patients without CW (þ4.61 ms
vs. –4.35ms, respectively; p¼ 0.0001). This increase in
RVD was coupled with a 15  12% increase in PVR, no
signiﬁcant modiﬁcation of cardiac index and right
TABLE 5 Univariate Analysis of Clinical, Echocardiographic, and
Hemodynamic Variables Associated With Clinical Worsening
Unit HR 95% CI p Value
Age, yrs 1 1.01 0.98–1.04 NS
Sex 0.70 0.28–1.74 NS
WHO 1 6.6 3.30–13.2 <0.0001
6MWT, m 1 0.99 0.98–0.99 <0.0001
Hemodynamics
Mean PAP, mm Hg 1 1.06 1.03–1.09 <0.0001
RAP, mm Hg 1 1.16 1.08–1.24 <0.0001
Cardiac index, l/min/m2 1 0.12 0.06–0.25 <0.0001
PVR, WU 1 1.28 1.18–1.39 <0.0001
Echocardiography
RA area, cm2 1 1.08 1.05–1.11 <0.0001
LVEId 1 10.3 4.23–25.03 <0.0001
LVEIs 1 3.41 2.17–5.33 <0.0001
RVEDA, cm2 1 1.08 1.04–1.13 <0.0001
RVESA, cm2 1 1.11 1.06–1.17 <0.0001
RVFAC, % 1 0.92 0.88–0.96 <0.0001
TAPSE, mm 1 0.84 0.76–0.92 <0.0001
Pericardial effusion 2.73 1.26–5.91 0.011
pTDI S1, cm/s 1 0.77 0.65–1.11 NS
pTDI S2, cm/s 1 0.86 0.75–1.06 NS
pTDI RV IVA, m/s2 1 0.24 0.12–0.46 <0.0001
Peak 2DS mid RVFW, ms 1 0.87 0.82–0.93 <0.0001
Peak 2DS basal RVFW, ms 1 0.85 0.79–0.91 <0.0001
RV-SD4, ms 1 1.03 1.01–1.03 <0.0001
CI¼ conﬁdence interval; HR¼ hazard ratio; other abbreviations as in Tables 1 and 2.
TABLE 6
Model 1
WHO IV
6MWT
Cardiac
Model 2
WHO IV
6MWT
Cardiac
RV-SD4
Model 1 (ch
p < 0.0001
df ¼ degr
2, and 3.
FIGURE 3 Comparison of the ROC Curves for Prediction of
Clinical Worsening Between the Baseline Model and the
Model Containing RV-SD4
Model-1
AUC 0.74
p = 0.005
Model-2
AUC 0.81
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Baseline model is model 1 (pink dashed line), and the model
containing RV dyssynchrony (RV-SD4) is Model 2 (green solid
line). A signiﬁcant improvement in accuracy is observed for
model 2 in predicting clinical worsening (0.74 vs. 0.81;
p ¼ 0.005; 95% CI: 0.02 to 0.11). AUC ¼ area under the
curve; ROC ¼ receiver operating characteristic; other
abbreviations as in Figure 1.
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648atrial pressure, and worsening of RV remodeling
parameters.
DISCUSSION
This is the ﬁrst prospective study in a large series of
consecutive IPAH, HPAH, and APAH therapy-naïve
patients that shows: 1) the high prevalence of RVD,Cox Regression Models for Clinical Worsening Prediction
Unit HR (95% CI) p Value
c-Statistic
(95% CI)
0.74 (0.62–0.85)
5.7 (1.19–27.9) 0.02
1 0.99 (0.98–0.99) 0.001
index 1 0.13 (0.05–0.30) 0.0001
0.81 (0.70–0.91)
13.9 (2.13–92.0) 0.006
1 0.99 (0.98–0.99) 0.001
index 1 0.13 (0.05–0.35) 0.0001
$23 ms 3.8 (1.34–11.0) 0.01
i-square ¼ 49.37; df ¼ 3; p < 0.0001); model 2 (chi-square ¼ 57.02; df ¼ 4;
)
ees of freedom; WHO IV ¼WHO functional class IV; other abbreviations as in Tables 1,as already described in pediatric PAH patients (15);
2) the major determinants of RVD as increased
afterload, morphologic RV remodeling, and to a
lesser extent QRS duration; 3) RVD as an indepen-
dent prognostic factor together with WHO functional
class IV, 6MWT, and cardiac index; and 4) the
reversibility of RVD when a large reduction of PVR is
achieved.
In comparison with previous studies, our popula-
tion consisted of a large homogeneous cohort of naïve
patients representative of the whole spectrum of the
disease stages and in the absence of confounding
factors. The few studies available on this issue have
been considering only smaller samples of prevalent
pulmonary hypertension patients with possible con-
founding factors such as associated PAH disease and
other comorbidities (4–6,16).
RV DYSSYNCHRONY MODELS BY STE ANALYSIS. In
contrast to conventional tissue Doppler imaging
(TDI), angle independence and an improved signal-
to-noise ratio are the main advantages of the STE
method to overcome limitations in the assessment of
strain values (11). Furthermore, longitudinal strain
FIGURE 4 Event-Free Survival of Patients With a RV-SD4 $23 ms Compared to
Patients With a RV-SD4 <23 ms
p = 0.0002
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Abbreviations as in Figure 1.
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649analysis by STE has been found to reﬂect the systolic
myocardial contractile delay more accurately than
using the wall velocities, as with TDI (11).
The higher variability of the time-to-peak strain
of the apical segments found in normal subjects
can be explained by several technical limitations
(11,17,18): image quality related to near-ﬁeld arti-
facts; inadequate frame rate due to the wide sector
angle that is necessary to visualize the entire
remodeled RV apex; the assumption that morpho-
logic details can be tracked from one frame to the
next, which may not be true for the RV apical seg-
ments where out-of-plane motion occurs; STE is not
completely angle independent, presenting worse
resolution for the remodeled RV apex. For these
technical reasons we have excluded RV apical seg-
ments for RVD evaluation as the results appeared to
be inconsistent.
DETERMINANTS OF RV DYSSYNCHRONY. Our ﬁnd-
ings clearly indicate that in IPAH, HPAH, and APAH,
RVD is mainly explained by the combined effect of
increased PVR, RV chamber dilation, and QRS dura-
tion. These 3 factors may contribute to dyssynchro-
nous RV wall motion with several pathophysiological
mechanisms.
Data are available from the large experience in left
heart disease showing that an increased afterload
plays an important role as a cause of LV dyssynchrony
even in the presence of narrow QRS complexes
(19,20). Indeed, afterload per se seems to induce LV
dyssynchrony in normal subjects during a pharma-
cological challenge in the absence of other con-
founding factors (21). In PAH patients, it has been
shown that RV wall stress correlates with regionalTABLE 7 Differences During Follow-Up in Clinical, Hemodynamic, RV
Clinical Worsening
Basal 12 months D
WHO 3.1  0.3 3.2  0.3 þ0.1 
6MWT, m 367  68 326  73 –42 
PAP, mm Hg 56  14 58  12 þ2 
RAP, mm Hg 9  5 10  4 þ0.8 
Cardiac index,
l/min/m2
2.0  0.4 1.9  0.3 –0.06 
PVR, WU 13.8  5.5 15.3  5.0 þ1.5 
RA area, cm2 37  10 39  9 þ1.5 
LVEId 1.56 (1.27 to 2.07) 1.56 (1.40 to 1.90) 0.05 (–0.39 t
LVEIs 1.81 (1.50 to 2.19) 1.90 (1.62 to 2.47) 0.09 (–0.38 t
RVEDA, cm2 30  8 34  6.5 þ3.8 
RVESA, cm2 21  6 25  6.5 þ4 
RV-SD4, ms 45.40  28 49.75  26 þ4.61 
Values are mean  SD.
RVD ¼ right ventricular dyssynchrony; other abbreviations as in Tables 1, 2, and 3.differences in the duration of contraction between
the RV FW and left ventricular lateral wall, measuring
times-to-peak myocardial shortening by magnetic
resonance imaging (6). Thus, nonuniform distribution
of regional myocardial wall stress is very likely a
major determinant of RVD. Moreover, the interplay
between RV dilation and afterload in inducing RVD
has been documented in animal models in which RV
dilation, induced by increased afterload, has been
associated with changes in RV action potentialMorphological Parameters, and RVD Between Patients With and Without Clinical Worsening
No Clinical Worsening
p Value Basal 12 months D p Value
0.3 NS 2.4  0.5 1.8  0.3 –0.6  0.5 0.0001
28 0.0001 476  99 508  77 þ32  33 0.0001
4 0.03 45  13 38  11 –7  7 0.0001
1.9 NS 6  3 5  1 –1.3  2.6 0.001
0.2 NS 3.0  0.6 3.1  0.5 þ0.1  0.2 0.001
1.3 0.0001 7.2  3 5.6  2.0 –1.6  1.2 0.0001
2.2 0.007 26  7 24  6 –1.2  2.0 0.0001
o 0.19) 0.001 1.21 (1.08 to 1.32) 1.16 (1.09 to 1.25) –0.01 (–0.07 to 0.00) 0.001
o 0.28) 0.0001 1.25 (1.15 to 1.57) 1.19 (1.12 to 1.41) –0.04 (–0.12 to 0.01) 0.0001
2.8 0.0001 23  7 22  6 –1.0  2.7 0.01
2.7 0.0001 14  6 12  5 –1.2  2.7 0.002
9.3 0.01 19.57  14 14.96  10 –4.35  7.6 0.001
FIGURE 5 Correlation Between the Changes in RV-SD4 and PVR During Follow-Up
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Quadratic model: r2 ¼ 0.59, p ¼ 0.0001, y ¼ 4.1 þ 0.21x -0.007x2; linear model: r2 ¼
0.44, p ¼ 0.0001, y ¼ 1.39 þ 0.31x. Patients with and without clinical worsening are
reported in the same scatterplot (green circles and blue circles, respectively). PVR ¼
pulmonary vascular resistance; other abbreviations as in Figure 1.
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650duration and conduction properties by altering cell-
to-cell coupling (22). Similar results have been found
by Hardziyenka et al. (16) in chronic thromboembolic
pulmonary hypertension patients, conﬁrming that
increased RV size is a contributing factor to inter-
ventricular delay by electrophysiological epicardial
mapping during pulmonary endarterectomy.
Finally, not surprisingly, we found that QRS dura-
tion is the third independent factor for RVD, although
multivariate analysis confers the prevalent role to
PVR and RV dilation. This ﬁnding is in contrast to
Kalogeropoulos et al. (5), who failed to show a sig-
niﬁcant correlation between RVD and QRS duration,
but that study included a smaller and more hetero-
geneous population of PAH patients, making those
ﬁndings quite inconsistent.
In this pathophysiologic condition, RVD means
that the late phase of RV contraction may not
contribute to stroke volume (i.e., post-systolic short-
ening). In patients with RVD, post-systolic shortening
was 10  13% of total RV shortening, reaching up to
17  9% in those with RVD >23 ms (range 3% to 31%).
According to our results, inefﬁcient RV shortening
may facilitate cardiac index reduction, despite no
signiﬁcant differences of most RV systolic function
parameters between patients with and without RVD.
This is in agreement with and extends the ﬁndings ofMarcus et al. (6) who observed a negative correlation
between prolonged RV shortening and RV stroke
volume.
PREDICTORS OF CLINICAL WORSENING. It is widely
accepted that RV function is the primary determinant
of prognosis in PAH. Our results conﬁrm the prognostic
relevance of WHO functional class IV, 6MWT, and
cardiac index, directly related to RV function, and
identify RVD as a new independent prognostic factor.
WHO functional class IV, 6MWT, and cardiac index
have been historically associated with prognosis
since before modern treatments were available (23),
and the importance of these parameters has been
conﬁrmed in modern registries, such as the French
and the Reveal registry (8,24), emphasizing invasive
hemodynamic evaluation as mandatory in all PAH
naïve patients.
Furthermore, we documented for the ﬁrst time
that RVD is an independent predictor of unfavorable
clinical events in IPAH, HPAH, and APAH patients.
Patients with RV-SD4 $23 ms have a 3.8-fold
increased risk of CW on long-term follow-up. RV-SD4
evaluation added signiﬁcant prognostic information
to well-established clinical, hemodynamic, and
echocardiographic data, as shown by the incremental
value of the c-statistic. Interestingly, almost all the
patients without CW in our cohort had an RV-SD4
below the normal limit (18 ms) at the time of diag-
nosis, emphasizing the potential role in clinical
practice. Because of its high negative predictive
value, physicians could be reassured on a more
favorable course of the disease for those patients
without RVD at diagnosis, especially if matching with
other well-known predictive functional and hemo-
dynamic variables.
RV DYSSYNCHRONY EVOLUTION. Our ﬁndings show
for the ﬁrst time that RVD in PAH can be reversed by a
remarkable decrease in PVR. As can be seen in
Figure 5, a nonlinear relationship is present between
RV-SD4 and PVR, showing a signiﬁcant decrease in
RVD when large PVR reduction can be reached and
allowing full normalization in 10 patients. Such
hemodynamic improvement is associated with a sig-
niﬁcant reduction of RV dilation related to RV-SD4
reduction, contributing to normal restoration of RV
shortening times.
Follow-up data conﬁrm the important role of PVR
and RV size on determining RVD, emphasizing how RV
wall stress could be the common denominator
affecting RV regional differences in shortening time.
STUDY LIMITATIONS. Our study cohort consisted of
patients referred to a single tertiary center, which
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Prognosis in PAH
depends on the ability of the RV tomaintain its function in the face
of increased afterload. RVD has been described in PAH, but no
evidence is available on its prognostic impact and evolution after
therapy.
COMPETENCY IN PATIENT CARE: RVD is not uncommon in
pulmonary arterial hypertension, it might regress during effective
treatments and represents a noninvasive parameter with an in-
dependent prognostic impact on clinical worsening, increasing the
prognostic power of the model based on traditional clinical,
hemodynamic, and echocardiographic parameters.
TRANSLATIONAL OUTLOOK: The results of this study should
be conﬁrmed in a larger, multicenter trial focusing on changes in
RVD during targeted PAH therapy, and its impact on survival.
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651might constitute a referral bias. However, this is a
common limitation of similar studies.
The second limitation is that the duration of dis-
ease may inﬂuence the development of RVD, its
reversibility, and patient prognosis. However, deter-
mining the onset and duration of disease in PAH is
challenging. We are therefore unable to evaluate its
inﬂuence on RVD.
Another limitation arises from a possible type I
error inﬂation given the multiple screened predictors
in light of the relatively small number of patients with
events.
Finally, a possible technical limitation comes from
STE analysis, which requires a training period and
experience to achieve reproducible results. Two spe-
ciﬁc limitations of STE are the need of good image
acquisition to obtain adequate endocardial border
delineation and the inability to use this technique in
nonsinus rhythms (25).
CONCLUSIONS
The results of the present study extend the sparse
data on RVD, deﬁning a robust pathophysiologic
model of RVD determining factors, which emerged as
the combination of PVR, RVEDA, and QRS duration.
This model may provide further insight into the un-
derstanding of RV adaptation to increased afterload
in IPAH, HPAH, and APAH.
The most important ﬁndings of our study are the
demonstration of the independent prognostic impact
of RV-SD4 as a new noninvasive parameter with
high negative predictive value and the possibility of
RVD regression for large decreases in PVR with PAH
therapies. Our ﬁndings should be conﬁrmed in alarger multicenter trial focusing on changes in RVD
during targeted PAH therapy and its impact on
survival.
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